Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
about
Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and CarvedilolDifferential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humansEvolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failureExpanding role of beta-blockade in the management of chronic heart failure.Bucindolol: a pharmacogenomic perspective on its use in chronic heart failureBeta-blocker benefit according to severity of heart failure.Can antiarrhythmic drugs save lives in patients with congestive heart failure?New developments in the use of beta-blockers for the management of heart failure.Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.Beta-blocker therapy of heart failure: an update.Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European TrialCarvedilol in the treatment of elderly patients with chronic heart failure.Pharmacogenomics of heart failure: a systematic review.Role of β-blocker therapy in pediatric heart failureA Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart.Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
P2860
Q27679036-06F66246-0675-4C01-9086-4596261E829DQ31131385-81B594C5-CF7D-4EAA-BC8C-DA26818CC421Q34837191-1E39E247-B8FC-41A3-A054-09181EA9948EQ34872068-6E7AF752-1C66-4AF1-96BF-321CE2CB0728Q35101463-00577AEE-36DE-4F2C-8585-F9C7B091E388Q35117742-39B2F954-672E-4CDC-9A4B-1FE42B92DC6BQ35150702-579C7155-BB32-4D86-B20E-A4CA2881381FQ35696418-C88A9756-36DE-409F-8117-54F62E6C876FQ35842541-B57DB061-8611-43A6-86EB-7633BA0137C6Q35848432-16DBDB57-0509-43B1-A44C-F9F019B10C98Q36092158-88A8AF25-5624-445B-8D13-B15B62455FD9Q36723828-168FDB6E-A496-40E2-981B-157BE9B6DFC1Q36855013-D06CEA4F-5965-4CEA-85F5-97418C34BCD4Q36892905-978AFAD5-0B1E-4875-8468-47BB74ED43BAQ38998634-B7EC5E31-206E-4ADB-84D2-9FDC90B6E79FQ42034500-DFBAD777-1145-42E9-8A5C-EE04020D608EQ42070109-80FEA64F-742A-4E06-BC1A-46184B221199Q42191909-02073B52-2E01-4555-BAF9-CB57500C6118
P2860
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
@en
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
@nl
type
label
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
@en
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
@nl
prefLabel
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
@en
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
@nl
P2093
P1433
P1476
Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
@en
P2093
Eliot H Ohlstein
Jian Qin Wei
Keith A Webster
Leslie C Olson
Mark S Turner
Nambi Aiyar
Nanette H Bishopric
Peter Andreka
P304
P356
10.1161/01.CIR.0000016050.79810.18
P407
P577
2002-05-01T00:00:00Z